Legal Opinion
Biovail Corp. v. U.S. Food & Drug Administration
District Court, District of Columbia
Decided September 6, 2006No. Civil Action 06-1487 (RMU)PublishedCited by 19 opinions
1Opinion of the Court
MEMORANDUM OPINION
Denying the Plaintiffs’ Motion for a Temporary Restraining Order
URBINA, District Judge.
I. INTRODUCTION
The plaintiffs, Biovail Corporation and Biovail Laboratories International SRL (collectively, “the plaintiff’ or “Biovail”) manufacture the drug Wellbutrin XL. De-fendanWIntervenor Anchen Pharmaceuticals, Inc. (“Anchen”) is awaiting defendant Food & Drug Administration’s (“FDA”) 1 approval of its generic version of Wellbut-rin XL. In December 2005, Biovail filed a citizen petition 2 with the defendant to raise Biovail’s concerns regarding.the defendant’s evaluation of…
2Cases cited33 opinions
- Mathews v. EldridgeSupreme Court of the United States · 1976
- Motor Vehicle Mfrs. Assn. of United States, Inc. v. State Farm Mut. Automobile Ins. Co.Supreme Court of the United States · 1983
- Citizens to Preserve Overton Park, Inc. v. VolpeSupreme Court of the United States · 1971
- Paul v. DavisSupreme Court of the United States · 1976
- Califano v. SandersSupreme Court of the United States · 1977
28 more not listed; retrieve them via the Exa API.
3Cited by19 opinions
- Hi-Tech Pharmacal Co. v. United States Food & Drug AdministrationDistrict Court, District of Columbia · 2008
- Viropharma Incorporated v. HamburgDistrict Court, District of Columbia · 2012
- Citizens for Responsibility & Ethics in Wash. v. U.S. Dep't of Homeland Sec.Court of Appeals for the D.C. Circuit · 2019
- Astrazeneca Pharmaceuticals Lp v. Food and Drug AdministrationDistrict Court, District of Columbia · 2012
- Hill Dermaceuticals, Inc. v. U.S. Food & Drug AdministrationDistrict Court, District of Columbia · 2007
14 more not listed; retrieve them via the Exa API.